Helicobacter Pylori Diagnostics Market Size, Share & Growth Forecast 2026–2034

The global Helicobacter Pylori Diagnostics Market is witnessing steady growth due to the increasing prevalence of gastrointestinal disorders, rising awareness of early disease detection, and growing adoption of advanced diagnostic technologies. Helicobacter pylori infection is a major cause of chronic gastritis, peptic ulcers, and gastric cancer, making accurate and timely diagnosis essential. Increasing investments in molecular diagnostics, non-invasive testing methods, and laboratory automation are further driving market expansion.

According to Fortune Business Insights, the global helicobacter pylori diagnostics market was valued at USD 750.26 million in 2025 and is projected to grow from USD 795.04 million in 2026 to USD 1,264.18 million by 2034, exhibiting a CAGR of 5.97% during the forecast period.

Why is the Helicobacter Pylori Diagnostics Market Growing?

The increasing burden of gastrointestinal diseases and growing emphasis on early diagnosis are among the primary factors driving the Helicobacter Pylori Diagnostics Market. Healthcare providers are increasingly adopting rapid, accurate, and non-invasive diagnostic methods to improve patient outcomes and reduce complications associated with H. pylori infections.

The growing adoption of molecular diagnostics, PCR-based testing, stool antigen tests, and urea breath tests is further accelerating market growth. Rising awareness regarding antibiotic resistance and personalized treatment approaches is also encouraging the use of advanced diagnostic solutions.

Helicobacter pylori diagnostic solutions are widely used for:

Hospital laboratories
Diagnostic laboratories
Gastroenterology clinics
Point-of-care testing
Preventive health screening
Gastric cancer risk assessment
Infection monitoring
Clinical research

Growing investments in precision diagnostics and laboratory modernization continue to create significant opportunities for market participants.

Key Market Trends Shaping Industry Growth

Rising Adoption of Non-Invasive Diagnostic Tests

Healthcare providers are increasingly preferring stool antigen tests and urea breath tests due to their high accuracy, patient convenience, and reduced need for invasive endoscopic procedures.

Growing Integration of Molecular Diagnostics

PCR-based assays and molecular diagnostic platforms are gaining popularity because they enable rapid detection of Helicobacter pylori and identification of antibiotic-resistant strains, supporting personalized treatment strategies.

Expansion of Point-of-Care Testing

The demand for portable and rapid diagnostic systems is increasing across outpatient clinics and decentralized healthcare settings, improving accessibility and reducing diagnosis time.

Increasing Use of AI and Laboratory Automation

Diagnostic laboratories are integrating artificial intelligence and automated laboratory workflows to improve testing accuracy, efficiency, and clinical decision-making.

For detailed market insights: https://www.fortunebusinessinsights.com/helicobacter-pylori-diagnostics-market-116631

Market Segmentation Analysis

Non-Invasive Testing Segment Leads the Market

Based on test type, the Non-Invasive Testing segment accounted for the largest market share in 2025 due to increasing adoption of stool antigen tests, urea breath tests, and serological testing that offer faster diagnosis and greater patient comfort.

Hospitals & Diagnostic Laboratories Segment Dominates Market Demand

Based on end user, the Hospitals & Diagnostic Laboratories segment held the largest market share owing to the increasing number of gastrointestinal disease diagnoses, availability of advanced laboratory infrastructure, and growing demand for accurate molecular testing.

Regional Insights

North America Leads the Global Market

North America accounted for the largest share of the global Helicobacter Pylori Diagnostics Market in 2025. Advanced healthcare infrastructure, increasing awareness of gastrointestinal diseases, expanding preventive screening programs, and widespread adoption of molecular diagnostics continue to support regional market growth. The United States remains the largest contributor to regional revenue.

Europe Maintains Strong Market Position

Europe continues to witness healthy market growth supported by increasing investments in diagnostic technologies, growing gastric cancer screening initiatives, and strong healthcare infrastructure. Germany, the United Kingdom, and France remain major regional markets.

Asia Pacific Witnesses Rapid Growth

Asia Pacific is expected to register significant growth during the forecast period due to the high prevalence of H. pylori infections, improving healthcare infrastructure, rising healthcare expenditure, and increasing awareness of early disease diagnosis. China, Japan, and India remain key regional growth markets.

Competitive Landscape

The global Helicobacter Pylori Diagnostics Market is highly competitive, with leading diagnostic companies focusing on rapid testing technologies, molecular diagnostics, laboratory automation, and non-invasive testing solutions. Manufacturers are investing in advanced PCR-based assays, stool antigen tests, urea breath tests, and AI-enabled diagnostic platforms to improve testing accuracy, reduce turnaround time, and enhance patient outcomes.

The increasing demand for early disease detection, personalized treatment approaches, and efficient gastrointestinal diagnostics is encouraging companies to expand their product portfolios and strengthen their global presence. Strategic partnerships, product launches, acquisitions, and investments in research and development continue to intensify market competition.

Major Companies Operating in the Helicobacter Pylori Diagnostics Market

Thermo Fisher Scientific Inc.
Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Bio-Rad Laboratories, Inc.
QIAGEN N.V.
Meridian Bioscience, Inc.
Sekisui Diagnostics
DiaSorin S.p.A.
QuidelOrtho Corporation
Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

These companies continue to strengthen their market position through innovative diagnostic technologies, strategic collaborations, global distribution expansion, and continuous product development.

Recent Industry Developments

Leading diagnostic companies are introducing rapid and non-invasive Helicobacter pylori testing solutions to improve patient comfort and diagnostic accuracy.
Manufacturers are expanding molecular diagnostic platforms capable of detecting H. pylori infections and identifying antibiotic-resistant strains to support personalized treatment decisions.
Increasing investments in laboratory automation and AI-powered diagnostic technologies are improving workflow efficiency and reducing diagnostic turnaround times.
Companies are strengthening global distribution networks and expanding regulatory approvals for advanced gastrointestinal diagnostic products.
Strategic collaborations, acquisitions, and continuous product innovation are accelerating the adoption of next-generation diagnostic solutions across hospitals and laboratories.

Future Outlook

The future of the Helicobacter Pylori Diagnostics Market appears highly promising as healthcare providers continue to prioritize early diagnosis, precision medicine, and improved gastrointestinal disease management. Rising awareness of gastric cancer prevention, increasing screening programs, and growing demand for rapid diagnostic testing are expected to support sustained market growth throughout the forecast period.

Technological advancements in molecular diagnostics, artificial intelligence, laboratory automation, and point-of-care testing are expected to enhance diagnostic accuracy, reduce testing time, and improve clinical decision-making. These innovations will enable healthcare providers to deliver faster and more personalized treatment strategies.

Emerging economies are expected to create significant growth opportunities due to expanding healthcare infrastructure, increasing healthcare expenditure, rising awareness of gastrointestinal diseases, and broader access to advanced diagnostic technologies. Companies that prioritize innovation, automation, regulatory compliance, and global market expansion are likely to strengthen their competitive position over the coming years.

Request Sample Report

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/helicobacter-pylori-diagnostics-market-116631

ABOUT

Fortune Business Insights™ provides strategic corporate analysis and comprehensive market intelligence that helps organizations make informed business decisions. Our reports combine in-depth market research with reliable industry data prepared by experienced analysts and consultants using advanced research methodologies. These insights help businesses identify emerging opportunities, evaluate competitive dynamics, and develop effective long-term growth strategies across multiple industries.